Your browser doesn't support javascript.
loading
Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy.
Lammoglia Cobo, María Fernanda; Welters, Carlotta; Rosenberger, Leonie; Leisegang, Matthias; Dietze, Kerstin; Pircher, Christian; Penter, Livius; Gary, Regina; Bullinger, Lars; Takvorian, Anna; Moosmann, Andreas; Dornmair, Klaus; Blankenstein, Thomas; Kammertöns, Thomas; Gerbitz, Armin; Hansmann, Leo.
Afiliação
  • Lammoglia Cobo MF; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Welters C; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Rosenberger L; Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Leisegang M; Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, Illinois, USA; German Cancer Consortium (DKTK), partner
  • Dietze K; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Pircher C; Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Penter L; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Gary R; Department of Internal Medicine 5-Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Bullinger L; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germa
  • Takvorian A; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Moosmann A; Department of Medicine III, Klinikum der Universität München, Munich, Germany; German Center for Infection Research (DZIF), Munich, Germany.
  • Dornmair K; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig Maximilian University of Munich, Munich, Germany.
  • Blankenstein T; Molecular Immunology and Gene Therapy, Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, Germany.
  • Kammertöns T; Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Gerbitz A; Hans Messner Allogeneic Stem Cell Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada.
  • Hansmann L; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germa
Cytotherapy ; 24(8): 818-826, 2022 08.
Article em En | MEDLINE | ID: mdl-35525797

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Herpesvirus Humano 4 / Infecções por Vírus Epstein-Barr Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Herpesvirus Humano 4 / Infecções por Vírus Epstein-Barr Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article